Summary In order to study the possible role of the T-lymphocyte growth factor, Interleukin 2 (IL-2), and/or of the IL-2 receptor in the autonomous growth of leukaemic cells, 15 mouse leukaemic cell lines of various aetiology were analyzed for (i) IL-2 receptor expression and (ii) for the capacity to secrete IL-2. Several but not all of the cell lines tested were IL-2 receptor positive. The cells constitutively expressing IL-2 receptors at their surface could not be stimulated to secrete IL-2. Cell producing and secreting IL-2 did not express detectable amounts of IL-2 receptors at their surface. It has been demonstrated that proliferation of the leukaemic cells was independent of exogenous IL-2. The monoclonal anti-IL-2 receptor antibody AMT-13 inhibited IL-2 dependent proliferation of activated normal T-lymphocytes but failed to inhibit the growth of IL-2 receptor expressing leukaemic cells. The results argue against the autocrine stimulation hypothesis but do not exclude the possibility of involvement of functionally altered IL-2 receptors on autonomous cell growth.
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For many, if not all cells, the initial trigger for proliferation appears to be the interaction of growth factors with the cell surface growth factor receptor. Activation of the growth factor receptor leads in turn to yet undefined cytoplasmic signalling systems.
Resting T lymphocytes are long living cells in the Go phase of the cell cycle. They only enter proliferative cycles under antigenic stimulation in the presence of a T cell growth factor, interleukin 2 (IL-2). Receptors for IL-2 are not detectable on the surface of resting T cells. Expression of IL-2 receptors is the consequence of interaction of antigen presenting cells with the antigen receptor. As shown recently, IL-2 receptor expression is a transient event and repeated restimulation by lectins (Cantrell & Smith, 1983; Dimantstain & Osawa, 1984) or the antigen (Reske-Kunz et al., 1984) is required for continuous IL-2 receptor expression and consequently for long term cell growth.
In contrast to activated normal T-cells, adult T leukaemic cells (ATL cells) constitutively express IL-2 receptors (Hattori et al., 1981; Yodoi et al., 1983 , Gallo et al., 1983 . It seemed plausible to us to ask whether the constitutive expression of the IL-2 receptor on leukaemic cells may be associated with the autonomous growth of the tumour cells. Recently we reported about the production and characterization of a monoclonal antibody (AMT-surface of activated murine T cells (Osawa & Diamantstein, 1984a, b) . The aims ofthe present report were (i) to search for IL-2 receptor expression on murine T leukaemic cells of various aetiology and (ii) to search for arguments for or against the autocrine stimulation hypothesis (Gallo & WongStaal, 1982) .
Materials and methods

Cell lines
The aetiology and origin of most of the tumour lines used has been described (Bosslet et al., 1979) .
The cell lines were grown in RPMI-1640 medium supplemented with 10% foetal calf serum and antibiotics as described (Bosslet et al., 1979) . Their characteristics relevant to the presented studies are indicated in Table I Diamantstein, 1980) . Metabolically blocked Tlymphoblasts were prepared by incubating Tlymphoblasts (106cells ml-1) with 50 pg ml-1 of mitomycin C at 37°C for 1 h as described previously (Reimann & Diamantstein, 1980 (Diamantstein et al., 1981 1OO p1 AMT-13 supernatant (dilution 1:3) or 10O,l medium as a control. After an incubation period of 30 min at 4°C, the cells were washed with 1 ml of medium and resuspended in 100ll 1251-labelled sheep anti-rat Ig, (Fab')2 fragment, diluted 1:10 (10 pCI g-1, 100 pCI ml-1, Amersham Buchler, Braunschweig, FRG). Sixty minutes later, the cells were washed twice and the radioactivity associated with the cell pellet was determined in a Packard Gamma spectrometer. Each cell population was tested in triplicate.
Attempts to induce IL-2 production Balb/c splenocytes or various lymphoma cell lines (2 x 106 cells ml-1) were incubated with lOng ml-1 of phorbolmyristate acetate (PMA, Sigma Miinchen, FRG) or 3 pg ml -of ConA or with a combination of PMA and ConA for 2 days (primary cultures). In order to defect IL-2 activity 0.02 ml of the respective culture supernatants containing 20mgml-1 of a-methylmannoside were added to 0.2ml of T-lymphoblasts (105 cellsml-1) and at day 3 of the culture period [3H]-thymidine uptake by the cells detected (secondary cultures).
Results
Detection of IL-2 receptors on murine lymphoma cell lines In order to search for IL-2 receptor bearing lymphomas, cells of 13 different murine T-lymphoma lines were incubated with the monoclonal rat anti IL-2 receptor antibody AMT-13 (Osawa & Diamanstein, 1984a) and subsequently with FITCconjugated anti-rat Ig. The results of the cytofluorometic analysis summarized in Table I show that some but not all lymphoma lines bind the McAb AMT-13 specifically.
Three out of the lymphoma cell lines were selected for a more detailed analysis: Eb-cells binding high level of AMT-13 antibody, Esb-cells binding a small but significant amount of AMT-13 antibody and EL-4 cells that failed to bind detectable amounts of AMT-13 antibody. The capacity of these cell lines to bind the antibody AMT-13 was compared to that of normal Tlymphoblasts by using a more sensitive indirect radioactive binding assay. Figure 4 , show that proliferation of normal Tlymphoblasts in response to IL-2 can be inhibited by the cocultured metabolically inactivated Tlymphoblasts. The inhibition of the response was specific, since addition of an excess of IL-2 to the cultures reversed the inhibitory activity of the metabolically blocked T-lymphoblasts. However, the proliferation of the lymphoma cells could not be inhibited by metabolically inactivated Tlymphoblasts.
Lack of inhibition of'proliferation of T-[rn7phonia cells hv the monoclonal ainti-IL-2 receptor antihody We previously reported that the McAB AMT-13 can inhibit IL-2 dependent proliferation of IL-2 receptor bearing cells (Osawa & Diamantstein, 1984a) . We therefore wanted to investigate the proliferation of IL-2 receptor bearing T-lymphoma cells can be inhibited by this antibody too. As a positive control T-lymphoblasts were cultured in the presence of a saturating amount of IL-2. The results of a typical experiment are summarised in Figure 5 . They show that the antibody AMT-13 inhibits the IL-2 driven proliferation of T-lymphoblasts but does not inhibit the proliferation of either IL-2 receptor positive (Eb and ESb) or IL-2 receptor negative (EL-4) lymphoma cells. 
Discussion
To the best of our knowledge this is the first description of IL-2 receptor expression on murine T cell tumours. Most previous studies on T cell growth factor receptors on tumours were concerned with human adult T cell leukaemias and lymphomas (ATL), which have been associated with a novel retrovirus HTLV. It had been hypothesized that the continuous proliferation of ATL cells may result from continuous stimulation of their own IL-2 receptors by the elaboration of IL-2 (Gallo et al., 1983) . In the ATL lines, however, no evidence for constitutive IL-2 production could be found (Yodoi et al., 1983; Arya et al., 1984) . Nevertheless, a possible functional role of IL-2 receptors on ATL cells is not excluded. Based on the observation that the putative physiologic regulation mechanism of IL-2 reccptor expression, down regulation of the receptor, is lacking in ATL cells (Tsudo et al., 1983) it was hypothesized that the "constitutive" Dilution of AMT-13 ascites (Altevogt & Schirrmacher, in press).
In contrast to the report of Farrar et al. (1982) the chemically induced Thus, the two lines Eb and ESb which expressed the receptor did not produce IL-2 to any detectable amount under any of the test conditions, while EL-4 cells, which did not express the receptor, could be stimulated to IL-2 production.
While these results gave no hint to a possible role of an autocrine stimulatory mechanism via IL-2 and IL-2 receptor in these T cell lymphomas, we still had to exclude the possibility that IL-2 might be produced only locally and become absorbed immediately by the tumour cell IL-2 receptors. This was excluded by the negative outcome of a competition assay with admixed metabolically blocked T lymphoblasts. (1982) . But such a mechanism has not been demonstrated for any cell type. It is also possible that in Eb cells as well as in ATL cells the mechanisms which lead to altered and tumorous growth have nothing to do with the IL-2/IL-2 receptor system. The tumour lines could be stimulated by other growth factors or they could produce factors which may mimic the functional activity of a regulatory component along the intracellular signalling system. Experimental data have recently been summarized which support the notion that growth factor independence and autonomous growth of transformed cells might be due to a constitutive expression of any of the controlling elements along the normal mitogenic pathway -the growth factor itself, the membrane receptor that serves as a transducer of the extracellular signal, or the intracellular signal system which ultimately leads to the initiation of DNA synthesis and cell division. The constitutively expressed factors, which function as transforming proteins in the malignant cell, may be encoded by oncogenes or their expression may be under the control of oncogenes (Heldin et al., 1984) . Thus there are obviously several ways by which a transformed cell becomes independent of normal growth control. Which of these may be operative in the respective tumour lines studied remains to be elucidated. UCHIYAMA, T. & MAEDA, M. (1983) . T cell growth factor receptor in adult T cell leukemia. Blood, 62, 509.
